| 2025-11-05 | +32.1% | earnings | Seeking Alpha | Establishment Labs targets over $210M 2025 revenue as U.S. market share approaches 20% |
| 2025-11-05 | +32.1% | earnings | Seeking Alpha | Establishment Labs Holdings Inc. (ESTA) Q3 2025 Earnings Call Transcript |
| 2025-11-05 | +32.1% | earnings | Seeking Alpha | Establishment Labs GAAP EPS of -$0.38 beats by $0.15, revenue of $53.8M beats by $1.52M |
| 2025-11-05 | +32.1% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2025-01-13 | -27.9% | executive | Seeking Alpha | Establishment Labs falls 13%, CEO to step down |
| 2025-01-13 | -27.9% | legal | SEC EDGAR | ESTA 8-K: 2.02 (SEC Filing) |
| 2023-11-07 | -26.3% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2025-02-26 | +20.4% | earnings | Seeking Alpha | Establishment Labs GAAP EPS of -$1.19 misses by $0.55, revenue of $44.5M beats by $0.05M |
| 2025-02-26 | +20.4% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2025-02-27 | +18.9% | earnings | Seeking Alpha | Establishment Labs Holdings Inc. (ESTA) Q4 2024 Earnings Call Transcript |
| 2024-09-26 | +17.6% | legal | Seeking Alpha | Establishment Labs gets FDA approval for Motiva implants |
| 2024-09-26 | +17.6% | legal | SEC EDGAR | ESTA 8-K: 8.01 and (SEC Filing) |
| 2025-08-07 | -17.4% | earnings | Seeking Alpha | Establishment Labs GAAP EPS of -$0.57 misses by $0.04, revenue of $51.3M beats by $0.2M |
| 2025-08-07 | -17.4% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2024-02-28 | +14.9% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2024-01-09 | +14.2% | legal | SEC EDGAR | ESTA 8-K: 1.01, 2.02, 3.02, 7.01 (SEC Filing) |
| 2024-11-12 | -12.9% | legal | SEC EDGAR | ESTA 8-K: 1.01 and (SEC Filing) |
| 2021-11-09 | -9.5% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2025-04-10 | -9.4% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2022-11-07 | -9.2% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2026-03-02 | -8.8% | news | Insider Monkey | Stephens Sees Sustainable Growth for Establishment Labs Holdings Inc. (ESTA) Over the Coming Years |
| 2024-04-02 | +8.7% | legal | SEC EDGAR | ESTA 8-K: 8.01 (SEC Filing) |
| 2021-05-18 | +8.7% | legal | SEC EDGAR | ESTA 8-K: 5.02 and (SEC Filing) |
| 2025-04-21 | -8.6% | news | Seeking Alpha | Establishment Labs Holdings: Impressive Growth, Several Caveats |
| 2024-05-09 | +8.5% | earnings | Seeking Alpha | Establishment Labs Holdings Inc. (ESTA) Q1 2024 Earnings Call Transcript |
| 2022-05-09 | -7.6% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2023-02-27 | +7.3% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2023-08-08 | -7.3% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2025-10-03 | -7.2% | legal | SEC EDGAR | ESTA 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-08-08 | -7.1% | earnings | Seeking Alpha | Establishment Labs raises 2025 revenue guidance to $208M–$212M amid strong U.S. Motiva adoption and improved operating metrics |
| 2025-08-08 | -7.1% | earnings | Seeking Alpha | Establishment Labs Holdings Inc. (ESTA) Q2 2025 Earnings Call Transcript |
| 2026-03-09 | -6.5% | news | Motley Fool | Rice Hall James Buys QuidelOrtho Stock |
| 2026-03-09 | -6.5% | news | Motley Fool | Rice Hall James Buys Stride Stock |
| 2026-03-09 | -6.5% | news | The Motley Fool | Rice Hall James Buys QuidelOrtho Stock - The Motley Fool |
| 2026-03-09 | -6.5% | news | The Motley Fool | Rice Hall James Buys Stride Stock - The Motley Fool |
| 2024-11-07 | -6.5% | news | Seeking Alpha | Establishment Labs announces $50M registered direct offering |
| 2024-11-07 | -6.5% | earnings | Seeking Alpha | Establishment Labs GAAP EPS of -$0.59 beats by $0.02, revenue of $40.2M misses by $0.25M |
| 2024-11-07 | -6.5% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2021-12-13 | -6.4% | legal | SEC EDGAR | ESTA 8-K: 5.02 (SEC Filing) |
| 2023-12-14 | +6.2% | legal | SEC EDGAR | ESTA 8-K: 5.02 (SEC Filing) |
| 2022-04-28 | -6.2% | legal | SEC EDGAR | ESTA 8-K: 1.01, 2.03 (SEC Filing) |
| 2021-07-29 | +6.1% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2024-07-16 | +5.2% | legal | SEC EDGAR | ESTA 8-K: 8.01 (SEC Filing) |
| 2021-12-10 | -5.1% | legal | SEC EDGAR | ESTA 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-01-06 | +5.1% | news | AD HOC NEWS | Is Establishment Labs the Next Sleeper Stock Superstar or Just Surgical Hype? - AD HOC NEWS |
| 2022-01-10 | +5.1% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2024-08-07 | +5.1% | earnings | Seeking Alpha | Establishment Labs Holdings Inc. (ESTA) Q2 2024 Earnings Call Transcript |
| 2024-05-08 | +4.8% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2024-09-27 | +4.8% | legal | Seeking Alpha | Establishment Labs rallies 19% on Motiva FDA approval |
| 2026-01-12 | -4.7% | earnings | Seeking Alpha | Establishment Labs reports preliminary Q4 revenue between $64M to $65M |
| 2026-01-12 | -4.7% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2023-04-27 | -4.4% | legal | SEC EDGAR | ESTA 8-K: 1.01 and (SEC Filing) |
| 2021-07-12 | -4.3% | legal | SEC EDGAR | ESTA 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-05-07 | +4.3% | earnings | Seeking Alpha | Establishment Labs GAAP EPS of -$0.70 beats by $0.11, revenue of $41.4M beats by $0.29M |
| 2025-05-07 | +4.3% | executive | Seeking Alpha | Establishment Labs appoints Peter Caldini as CEO |
| 2025-05-07 | +4.3% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2025-05-07 | +4.3% | legal | SEC EDGAR | ESTA 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-25 | +4.2% | news | Insider Monkey | Establishment Labs Holdings (ESTA) Sees Impressive Growth with 20% Market Share in US Breast Aesthetics |
| 2026-01-03 | -4.2% | news | AD HOC NEWS | The Truth About Establishment Labs: Is This ‘Perfect Body’ Stock Really Worth the Hype? - AD HOC NEWS |
| 2025-05-14 | +4.1% | analyst | Seeking Alpha | Establishment Labs rises as Needham upgrades on easing trade war |
| 2022-12-02 | +3.7% | legal | SEC EDGAR | ESTA 8-K: 5.02 and (SEC Filing) |
| 2026-04-20 | -3.6% | news | Stock Traders Daily | (ESTA) Movement as an Input in Quant Signal Sets - Stock Traders Daily |
| 2023-01-09 | -3.6% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2024-10-02 | +3.2% | news | Seeking Alpha | Establishment Labs gains as first patients receive Motiva implants |
| 2022-08-19 | -3.2% | legal | SEC EDGAR | ESTA 8-K: 5.02 and 8.01 (SEC Filing) |
| 2024-08-06 | +3.1% | earnings | Seeking Alpha | Establishment Labs GAAP EPS of -$0.62 misses by $0.11, revenue of $44.1M beats by $1M |
| 2024-08-06 | +3.1% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2022-03-01 | +3.0% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2026-02-24 | +2.9% | earnings | Seeking Alpha | Establishment Labs targets at least 25% revenue growth in 2026 while expanding minimally invasive platforms |
| 2026-02-24 | +2.9% | earnings | Seeking Alpha | Establishment Labs Holdings Inc. (ESTA) Q4 2025 Earnings Call Transcript |
| 2026-02-24 | +2.9% | earnings | Seeking Alpha | Establishment Labs GAAP EPS of -$0.09 beats by $0.13, revenue of $64.62M beats by $0.5M |
| 2026-02-24 | +2.9% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2025-05-22 | +2.7% | legal | SEC EDGAR | ESTA 8-K: 4.01, 8.01 (SEC Filing) |
| 2022-08-08 | -2.5% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2023-04-24 | -2.4% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2026-03-12 | -2.3% | news | Motley Fool | Dave Stock Soars 150% in a Year as Newly Disclosed $7 Million Buy Signals Confidence in Fintech Upstart |
| 2023-05-08 | +2.2% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2026-04-02 | +2.2% | news | Stock Titan | ESTABLISHMENT LABS (ESTA) director exercises stock options, now holds 175,382 shares - Stock Titan |
| 2024-11-09 | -2.2% | earnings | Seeking Alpha | Establishment Labs Holdings Inc. (ESTA) Q3 2024 Earnings Call Transcript |
| 2022-09-02 | +2.1% | legal | SEC EDGAR | ESTA 8-K: 5.02 (SEC Filing) |
| 2026-04-01 | +1.9% | analyst | Simply Wall St. | How The Establishment Labs (ESTA) Story Is Shifting As Analysts Rework Valuations |
| 2022-06-06 | +1.8% | legal | SEC EDGAR | ESTA 8-K: 1.01 and (SEC Filing) |
| 2021-07-15 | +1.8% | legal | SEC EDGAR | ESTA 8-K: 5.02 and (SEC Filing) |
| 2026-04-23 | -1.6% | news | Business Wire | Establishment Labs® to Announce First Quarter 2026 Financial Results on May 6 |
| 2026-01-14 | +1.5% | news | Seeking Alpha | Establishment Labs Holdings Inc. (ESTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2024-08-26 | +1.5% | legal | SEC EDGAR | ESTA 8-K: 5.02 and (SEC Filing) |
| 2021-05-05 | -1.4% | legal | SEC EDGAR | ESTA 8-K: 2.02 and (SEC Filing) |
| 2025-05-11 | -1.4% | earnings | Seeking Alpha | Establishment Labs Holdings, Inc. (ESTA) Q1 2025 Earnings Call Transcript |
| 2026-03-16 | +1.3% | news | Insider Monkey | Is Establishment Labs Holdings Inc. (ESTA) A Good Stock To Buy Now? |
| 2024-05-22 | -1.3% | analyst | Seeking Alpha | Citi upgrades Edwards, Tandem; cuts Nevro, Establishment Labs |
| 2026-02-05 | -1.1% | earnings | Seeking Alpha | Establishment Labs: The Pivot From Growth To Profitable Scale |
| 2024-02-22 | +1.1% | legal | SEC EDGAR | ESTA 8-K: 1.01 and (SEC Filing) |
| 2022-03-04 | +1.0% | legal | SEC EDGAR | ESTA 8-K: 5.02 (SEC Filing) |
| 2024-01-31 | +0.7% | legal | SEC EDGAR | ESTA 8-K: 8.01 and (SEC Filing) |
| 2024-06-05 | +0.7% | legal | SEC EDGAR | ESTA 8-K: 8.01 (SEC Filing) |
| 2022-06-01 | -0.2% | legal | SEC EDGAR | ESTA 8-K: 8.01 (SEC Filing) |
| 2026-04-07 | +0.2% | news | Business Wire | Establishment Labs® Surpasses More Than Five Million Motiva® Devices in Market |
| 2021-05-28 | -0.2% | legal | SEC EDGAR | ESTA 8-K: 5.02 and 5.07 (SEC Filing) |
| 2026-04-21 | -0.1% | news | Motley Fool | Establishment Labs Insider Sells 37,500 Shares as Stock Jumps 128% in a Year |